Xu Q - Search Results

1

CAR-T Cell Therapy: Challenges and Optimization.

Luo M, Zhang H, Zhu L, Xu Q, Gao Q. Luo M, et al. Among authors: xu q. Crit Rev Immunol. 2021;41(1):77-87. doi: 10.1615/CritRevImmunol.2021037253. Crit Rev Immunol. 2021. PMID: 33822526 Review.

2

GITR domain inside CAR co-stimulates activity of CAR-T cells against cancer.

Golubovskaya VM, Berahovich R, Xu Q, Zhou H, Xu S, Guan J, Harto H, Li L, Wu L. Golubovskaya VM, et al. Among authors: xu q, xu s. Front Biosci (Landmark Ed). 2018 Jun 1;23(12):2245-2254. doi: 10.2741/4703. Front Biosci (Landmark Ed). 2018. PMID: 29772559 Free article.

3

Therapeutic potential of CRISPR/Cas9 gene editing in engineered T-cell therapy.

Gao Q, Dong X, Xu Q, Zhu L, Wang F, Hou Y, Chao CC. Gao Q, et al. Among authors: xu q. Cancer Med. 2019 Aug;8(9):4254-4264. doi: 10.1002/cam4.2257. Epub 2019 Jun 14. Cancer Med. 2019. PMID: 31199589 Free PMC article. Review.

4

A single-cell approach to engineer CD8+ T cells targeting cytomegalovirus.

Wang F, Xu Q, Zhuang Z, Li Z, Gao Q, Huang Y, Luo Y, Zhang X, Zhu L, Chao CC. Wang F, et al. Among authors: xu q. Cell Mol Immunol. 2021 May;18(5):1326-1328. doi: 10.1038/s41423-020-0466-z. Epub 2020 May 25. Cell Mol Immunol. 2021. PMID: 32451452 Free PMC article. No abstract available.

5

The co-stimulation of anti-CD28 and IL-2 enhances the sensitivity of ELISPOT assays for detection of neoantigen-specific T cells in PBMC.

Tang Y, Zhu L, Xu Q, Zhang X, Li B, Lee LJ. Tang Y, et al. Among authors: xu q. J Immunol Methods. 2020 Sep-Oct;484-485:112831. doi: 10.1016/j.jim.2020.112831. Epub 2020 Aug 3. J Immunol Methods. 2020. PMID: 32758496

6

Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.

Zhu L, Yang P, Zhao Y, Zhuang Z, Wang Z, Song R, Zhang J, Liu C, Gao Q, Xu Q, Wei X, Sun HX, Ye B, Wu Y, Zhang N, Lei G, Yu L, Yan J, Diao G, Meng F, Bai C, Mao P, Yu Y, Wang M, Yuan Y, Deng Q, Li Z, Huang Y, Hu G, Liu Y, Wang X, Xu Z, Liu P, Bi Y, Shi Y, Zhang S, Chen Z, Wang J, Xu X, Wu G, Wang FS, Gao GF, Liu L, Liu WJ. Zhu L, et al. Among authors: xu q, xu x, xu z. Immunity. 2020 Sep 15;53(3):685-696.e3. doi: 10.1016/j.immuni.2020.07.009. Epub 2020 Jul 19. Immunity. 2020. PMID: 32783921 Free PMC article.

7

Single-cell transcriptome analysis of the heterogeneous effects of differential expression of tumor PD-L1 on responding TCR-T cells.

Ding R, Liu S, Wang S, Chen H, Wang F, Xu Q, Zhu L, Dong X, Gu Y, Zhang X, Chao CC, Gao Q. Ding R, et al. Among authors: xu q. Theranostics. 2021 Mar 5;11(10):4957-4974. doi: 10.7150/thno.55075. eCollection 2021. Theranostics. 2021. PMID: 33754038 Free PMC article.

8

Single-Cell Transcriptomics Reveals Killing Mechanisms of Antitumor Cytotoxic CD4⁺ TCR-T Cells.

Liang Y, Xu Q, Liu S, Li J, Wang F, Li Z, Liao L, Lu Y, Li Y, Mu F, Sun HX, Zhu L. Liang Y, et al. Among authors: xu q. Front Immunol. 2022 Jul 19;13:939940. doi: 10.3389/fimmu.2022.939940. eCollection 2022. Front Immunol. 2022. PMID: 35928827 Free PMC article.

9

Advancing CAR-based immunotherapies in solid tumors: CAR- macrophages and neutrophils.

Liang Y, Xu Q, Gao Q. Liang Y, et al. Among authors: xu q. Front Immunol. 2023 Nov 28;14:1291619. doi: 10.3389/fimmu.2023.1291619. eCollection 2023. Front Immunol. 2023. PMID: 38090576 Free PMC article. Review.

10

Generation of CAR-T Cells for Cancer Immunotherapy.

Xu Q, Harto H, Berahovich R, Xu S, Zhou H, Golubovskaya V, Wu L. Xu Q, et al. Among authors: xu s. Methods Mol Biol. 2019;1884:349-360. doi: 10.1007/978-1-4939-8885-3_24. Methods Mol Biol. 2019. PMID: 30465215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18,789 results

Search Page